Dasatinib-induced follicular lymphoid hyperplasia, an entity to know

被引:0
|
作者
Phelippeau, Mona [1 ]
Lefebvre, Christine [2 ]
Jacob, Marie-Christine [3 ]
Syrykh, Charlotte [4 ]
Ghelfi, Julien [5 ]
Carras, Sylvain [2 ,6 ,7 ]
Laurent, Camille [4 ]
Molina, Lysiane [7 ]
Valmary-Degano, Severine [1 ,6 ]
机构
[1] CHU Grenoble Alpes, Serv Anat & Cytol Pathol, F-38000 Grenoble, France
[2] CHU Grenoble Alpes, Lab Hematol, F-38000 Grenoble, France
[3] CHU Grenoble Alpes, Lab Immunol, F-38000 Grenoble, France
[4] Inst Univ Canc Toulouse, Toulouse Oncopole, Serv Anat & Cytol pathol, F-31000 Toulouse, France
[5] CHU Grenoble Alpes, Dept Radiol, F-38000 Grenoble, France
[6] Univ Grenoble Alpes, Inst avancee Biosci IAB, Inserm U1209, CNRS UMR5309, F-38000 Grenoble, France
[7] Ctr Hosp Univ Grenoble Alpes, Serv dhematol, F-38000 Grenoble, France
关键词
Follicular lymphoid hyperplasia; Dasatinib; Side effects; Drug induced lymphadenopathy; TYROSINE KINASE INHIBITOR; LEUKEMIA;
D O I
10.1016/j.annpat.2022.09.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Follicular lymphoid hyperplasia induced by dasatinib is an entity recently described. It is sometimes difficult to rule out the diagnostic of small B-cell lymphoma. Usually, the node is swollen, with follicular architecture conserved, composed by germinal centers with variable size and shape, with a hight number of mitoses and tingible bodies macrophages inside. Follicular lymphoid hyperplasia is isolated or associated with multiple reactive patterns. The immunohistochemical profil of germinal centers is CD20+, CD10+, BCL6+, BCL2-. Swollen node disappears in a short time after dasatinib discontinuation. Clinicians and pathologists need to be aware of this entity, so as not to avoid mistakenly suspect lymphoma when lymphadenopathy occurs in a patient with chronic myeloid leukemia treated with dasatinib. (c) 2022 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [21] Dasatinib-Induced Pulmonary Arterial Hypertension
    Orlikow, Evan
    Weatherald, Jason
    Hirani, Naushad
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (11) : 1604.e1 - 1604.e3
  • [22] DASATINIB-INDUCED PULMONARY ARTERIAL HYPERTENSION
    Zeb, Hassan
    El-Kersh, Karim
    CHEST, 2019, 156 (04) : 62A - 62A
  • [23] Dasatinib-Induced Pulmonary Arterial Hypertension
    Zeb, Hassan
    El-Kersh, Karim
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E695 - E696
  • [24] Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review
    Bouquet, Emilie
    Jourdain, Anne
    Machet, Marie-Christine
    Beau-Salinas, Frederique
    Jonville-Bera, Annie-Pierre
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [25] Dasatinib-Induced Bilateral Chylothorax: A Case Report
    McGonegal, Caitlin E.
    Baskar, Sujatha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [26] Dasatinib-Induced Nephrotic Syndrome: A Case Report
    ElShaer, Ahmed
    Almasry, Mazen
    Alawar, Maher
    Masoud, Hassan
    El Kinge, Abdul Rahman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [27] Dasatinib-induced nephrotic syndrome: a case of phenoconversion?
    Rogulj, Inga Mandac
    Matisic, Vid
    Arsov, Borna
    Boban, Luka
    Juginovic, Alen
    Molnar, Vilim
    Primorac, Dragan
    CROATIAN MEDICAL JOURNAL, 2019, 60 (03) : 250 - 254
  • [28] Y Dasatinib-induced colitis: a case report
    Tamilarasan, Aravind Gokul
    Katelaris, Peter
    Gasiorowski, Robin
    Liyanasuriya, Ranjalee
    PATHOLOGY, 2019, 51 (07) : 757 - 759
  • [29] Dasatinib-Induced Chylothorax In Chronic Myeloid Leukemia
    Baloch, Z. A. Qutrio
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Dasatinib-Induced Nephrotic-Range Proteinuria
    Wallace, Eric
    Lyndon, William
    Chumley, Phillip
    Jaimes, Edgar A.
    Fatima, Huma
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (06) : 1026 - 1031